Independent Effects of Physical Activity in Patients with Nonalcoholic Fatty Liver Disease Hepatology, Vol 50, No 1 : 6~76, 2009 Alexis St. George, Adrian.

Slides:



Advertisements
Similar presentations
Maenne Okunola Pharm D. Candidate: University of Georgia June 2012 Preceptor: Dr. Ali Rahimi.
Advertisements

Evaluation of Abnormal Liver Function Tests Dr Deb Datta Consultant Gastroenterolgist.
Predictors of Depressive Symptoms and Obesity in African-American Women Transitioning from Welfare to Work Mayola Rowser PhDc, DNP, FNP-BC, PMHNP.
Retinol Binding Protein-4 levels in thyroid overt and subclinical dysfunction Kokkinos Spiridon, Tiaka Elisavet, Manolakis Anastasios, Papanas Nikolaos,
Predictors of elevated transaminase levels in patients with central obesity V. Papastergiou, G. Ntetskas, L. Skorda, F. Lambrianou, K. Roufas, E. Asonitis,
Body Image and Weight Status among African American and Caucasian Overweight Postpartum Women Participating in a Weight Loss Intervention Lori Carter-Edwards,
Abstract Background Results Olivia Augustin, Lyddia Petrofsky, Kathryn Lyman, & Brittany Weiler Faculty Advisor: Dr. Don Bredle Department of Kinesiology,
Materials and methods Sadeghi Ramin, MD Nuclear Medicine Research Center, Mashhad University of Medical Sciences.
S_khalilzadeh. NAFLD and T2DM NAFLD is closely associated with features of the metabolic syndrome and is regarded as the hepatic manifestation of the.
Weight Loss via Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis Gastroenterology 2015, /j.gastro
1 Future Areas of Research Intervention Approaches Causes and Mechanisms of Overweight and Obesity Abdominal Fat, Body Weight and Disease Risk Assessment.
THE PRESENCE OF HEPATIC STEATOSIS WHEN NO OTHER CAUSES FOR SECONDARY HEPATIC FAT ACCUMULATION NAFLD MAY PROGRESS TO CIRRHOSIS AND IS LIKELY AN IMPORTANT.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
Michelle Koford Summer Topics Discussed Background Purpose Research Questions Methods Participants Procedures Instrumentation Analysis.
Non-alcoholic Fatty Liver Disease
Nutrition, Physical Activity, and BMI-for-Age Categorization of School-Aged Children in the Menomonie Area Lindsay Rozek, Food and Nutrition; Ann Parsons,
Other causes of Cirrhosis: Genetic eg. Wilson's Disease, Hemochromatosis Autoimmune eg. Autoimmune Hepatitis, Primary Biliary Cirrhosis, Primary Sclerosing.
Department of Medicine Grand Rounds Clinical Vignette Wednesday, March 4, 2009 Peter Shue, M.D.
The Use of Mortality Data to Improve Risk Assessment CTHOLUA Seminar February, 2011 Robert Stout, Ph.D., President and Director Clinical Reference Laboratory.
Examining The Effects of Detraining and Retraining on Health Outcomes in Community Fitness Program Participants Grotthus, J.L. and Dalleck, L. (Faculty.
“Reversing MetS (Metabolic Syndrome) with MSRP (Metabolic Syndrome Reversal Program) Through Integrative Whole Food Dietary Recommendations and Sprint.
Metabolic Syndrome Darwin Deen, MD, MS Albert Einstein College of Medicine Gina Lopez, MSII Sophie Davis School of Biomedical Education.
Handout Twelve: Design & Analysis of Covariance
CHAPTER 7: Obesity in Women. Introduction 68% of U.S. population is overweight or obese. Resulting medical and psychosocial difficulties can be debilitating.
By: Kristin Izzo Preceptors: Elizabeth Koustis, MS, RD Pamela Jessup, MS, RD WADE PARK NUTRITION CLINIC.
Approaches to quantitative data analysis Lara Traeger, PhD Methods in Supportive Oncology Research.
Supported by Virtual Poster Hall: Summary Slides Professor Stephan Matthaei Tuesday, September 15 th This Virtual Poster Hall session explores the relationship.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
School of Allied Health Professions & School of Medicine, Health Policy & Practice LAMP A pragmatic unblinded randomised controlled trial and economic.
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease : The St Francis Heart Study Randomized Clinical Trial Temitope Foster,
Jun Yu,1,2 Joseph Jao-Yiu Sung,1,2 Henry Lik-Yuen Chan1,2
Clinicaloptions.com/hepatitis NAFLD and NASH Prevalence in US Cohort Slideset on: Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty.
F. 정 회 훈 Am J Gastroenterol 2012;107:46-52 Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy:
PREVALENCE AND RISK FACTORS FOR NON- ALCOHOLIC FATTY LIVER DISEASE AMONG AN URBAN AGING ADULT SRI LANKAN POPULATION– RAGAMA HEALTH STUDY 7-YEAR FOLLOW.
Budesonide induces remission more effectively than Prednisone in a controlled trial of patients with Autoimmune Hepatitis GASTROENTEROLOGY 2010;139:1198–1206.
Statins The AURORA Trial Reference Fellstrom BC. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360. A.
Kris V. Kowdley, Patricia Belt, Laura A. Wilson, Matthew M. Yeh, Brent A. Neuschwander-Tetri, Naga Chalasani, Arun J. Sanyal, and James E. Nelson ; for.
By: Lori Sanderson, LCSW, MPH, PhD Date: April 26, 2016.
ALCOHOLIC LIVER DISEASE. Alcohol is one of the most common causes of chronic liver disease worldwide,In the UK, a unit of alcohol contains 8 g of ethanol.
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Giovanni Targher, Lorenzo Bertolini, Felice Poli,
Early Hepatitis B Virus DNA Reduction in Hepatitis B e Antigen–Positive Patients with Chronic Hepatitis B : A Randomized International Study of Entecavir.
R. Papani, A. G. Duarte, Y-L. Lin, G. Sharma
Multicenter, Placebo-Controlled Trial
Diagnostic Pathway for Chronic Liver Disease
High-intensity Treatment & Weight Reduction Goal Achievement with MOVE
Dr. Iram Shad PGT-Medicine MU-1, HFH,RWP
Why anxiety associates with non-completion of pulmonary rehabilitation program in patients with COPD? Dr Abebaw Mengistu Yohannes Associate Professor.
Comparison between the Effect of Six Weeks Morning or Evening Aerobic Exercise on Appetite and Anthropometric Indices Zahra Alizadeh, MD Assistant Professor.
Dr Iyat Abdul Sattar A study on the clinical & serolological markers of HBV among patients with chronic HBV infection in Babylon Dr Monem Makki Alshok.
Exercise Adherence in Patients with Diabetes: Evaluating the role of psychosocial factors in managing diabetes Natalie N. Young,1, 2 Jennifer P. Friedberg,1,
Coagulation/Fibrinolytic Factors in PCOS
Clinical outcome after SVR: Veterans Affairs
Osborne K.B., Davies S.J., Coppini D.V.
Doyle M. Cummings, Pharm.D.,FCP, FCCP
Does One Size Fit All in Obesity Management?
Heart Healthy Workouts
What You Will Do Identify changeable risk factors that affect your levels of health and personal fitness. Describe lifestyle choices that can improve overall.
Clinical outcome after SVR: ANRS CO22 HEPATHER
Impact of metabolic risk factors on HCC
Hepatitis C: After the Diagnosis
What You Will Do Identify changeable risk factors that affect your levels of health and personal fitness. Describe lifestyle choices that can improve overall.
Obesity and Weight Loss: How Can Cross-Functional Collaboration and Integrated Care Work in Practice?
Treating Obesity as a Disease: What Are the Underlying Causes?
Geisinger Obesity Institute
Chapter 1: The Health Benefits of Physical Activity
Volume 69, Issue 5, Pages (November 2018)
What You Will Do Identify changeable risk factors that affect your levels of health and personal fitness. Describe lifestyle choices that can improve overall.
In the name of Almighty, Eternal, Just And Merciful GOD
Combined Resistance and Aerobic Exercise Training Reduces Insulin Resistance and Central Adiposity in Obese Adolescent Females Michael D. Shukis, Elizabeth.
Fig. 4: Schematic, initial diagnostic algorithm for a patient presenting with mild aminotransferase abnormality. Fig. 4: Schematic, initial diagnostic.
Presentation transcript:

Independent Effects of Physical Activity in Patients with Nonalcoholic Fatty Liver Disease Hepatology, Vol 50, No 1 : 6~76, 2009 Alexis St. George, Adrian Bauman, Amanda Johnston, Geoffrey Farrell, Tien Chey, and Jacob George R2 이은정

Introduction NAFLD –commonest form of chronic liver disease –Elevated liver enzymes, metabolic risk The aims (1) the impact of a counseling-based lifestyle intervention on physical activity (PA) behavior (2) the relationship between changes in PA and fitness on liver enzymes and metabolic parameters (3) the extent of change in PA that is required to influence metabolic targets (4) whether the relationship between change and health outcomes was similar for both PA and objective cardiorespiratory fitness changes obesity, T2DM, insulin resistance

Patients and Methods Study group –enrolled from the Sydney West Area Health Service –NAFLD was diagnosed ; abnormal liver enzymes, a detailed history, and exclusion of other causes of liver disease –Other liver diseases ; hepatitis B (negative for HBs Ag), hepatitis C (negative for HCV Ab), autoimmune liver disease (ANA, AMA,, anti-LKM Ab), Wilson’s disease (serum copper and ceruloplasmin levels), alpha-1 antitrypsin deficiency (alpha-1 antitrypsin levels/genotype), and hemochromatosis (iron studies and genotyping for C268Y and H63D mutations) –alcohol >20 g/day in males and >10 g/day in females ; excluded

Patients and Methods Study design (141 patients were randomized) –Group A (n38) : low-intensity intervention (3 counseling sessions ; Baseline, Weeks 2 and 4) –Groups B (n33),C (n36) : moderate-intensity intervention in the first 3 months, comprising six fortnightly counseling sessions –Group C : additional longterm telephone support postintervention (3 to 12 months) to examine the effects of a maintenance program versus none –Control group (n34) : one consultation at baseline

Patients and Methods Measurement –To describe the effect of changes in PA : (1) increased PA (60 minutes/week) (2) those who maintained PA (above 150 minutes/ week at baseline and 3 months but did not increase) (3) low-active (decreased to or remained between minutes/week) (4) sedentary (decreased to or remained at 60 minutes/week) –Weight change categorized ; reduction of 3% of initial body weight

Patients and Methods Statistical Analysis –SPSS software (version 16.0, Chicago, IL) –ANOVA ; identify between-group differences –paired t-tests for all continuous variables –For analysis between groups, ANCOVA was used –Logistic regression analysis ; compare the prevalence of risk factors between groups at 3 months, with baseline –McNemars test was used and Pearson’s chi-square test was used to compare categorical data between groups

Results

No significant differences between anthropometric, metabolic variables or in physical activity

P<0.001

positive relationship between increasing PA and weight loss no clear relationship between PA increments and reductions in liver enzyme levels

Conclusion Lifestyle counseling interventions are effective in improving physical activity behavior Maintaining or increasing physical activity provides health benefits for patients with fatty liver, independent of changes in weight